Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xbiotech Inc (XBIT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 339,212
  • Shares Outstanding, K 36,048
  • Annual Sales, $ 0 K
  • Annual Income, $ -21,140 K
  • 60-Month Beta 0.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.89

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.30 +10.72%
on 04/17/19
11.60 -20.78%
on 04/01/19
-1.75 (-16.00%)
since 03/22/19
3-Month
5.44 +68.93%
on 01/28/19
11.74 -21.72%
on 03/21/19
+3.10 (+50.90%)
since 01/24/19
52-Week
2.13 +331.46%
on 09/11/18
11.74 -21.72%
on 03/21/19
+4.29 (+87.55%)
since 04/24/18

Most Recent Stories

More News
Research Report Identifies Net 1 UEPS Technologies, XBiotech, Rambus, Vector Group, Collectors Universe, and Gulf Island Fabrication with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Net 1 UEPS Technologies, Inc....

VGR : 10.11 (-5.60%)
UEPS : 3.55 (unch)
GIFI : 8.70 (-2.68%)
CLCT : 17.53 (-0.40%)
RMBS : 11.56 (+1.58%)
XBIT : 9.19 (-2.34%)
Restenosis Pipeline Review, H1 2019 - Therapeutics Assessment Report Featuring CytoTools AG & XBiotech Inc - ResearchAndMarkets.com

The "Restenosis - Pipeline Review, H1 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.Restenosis - Pipeline Review, H1 2019, provides comprehensive information...

CYTTF : 15.0000 (-12.54%)
XBIT : 9.19 (-2.34%)
Global Biotech Market Primed for Growth With Renewed Research and Development Efforts

Diseases are commonplace around the world, especially in regions that don't have access to adequate healthcare. They present themselves as various groups such as cancers, diabetes, skin, bacterial, as...

MGNX : 16.50 (-1.84%)
VYGR : 21.01 (+1.20%)
ZLAB : 29.06 (-3.97%)
PRTA : 10.94 (-2.15%)
ABBV : 78.67 (+0.01%)
XBIT : 9.19 (-2.34%)
PBIO : 3.5000 (+1.45%)
IMMU : 16.13 (-5.01%)
Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics

- Significant therapeutic benefit achieved whether or not patients had previously failed treatment with existing FDA-approved biological drug.

XBIT : 9.19 (-2.34%)
Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting

EQNX::TICKER_START (NASDAQ:XBIT), EQNX::TICKER_END

XBIT : 9.19 (-2.34%)
These 4 Biotech Stocks Are Leading The Industry

CORAL GABLES, FL / ACCESSWIRE / February 6, 2019 / The market has always been a sector replete with innovation, and conversation surrounding companies looking into nuanced approaches to designing effective...

NTGN : 5.85 (-5.80%)
BNGO : 4.12 (-1.19%)
XBIT : 9.19 (-2.34%)
94.7% Return Seen to Date on SmarTrend Xbiotech Inc Call (XBIT)

SmarTrend identified an Uptrend for Xbiotech Inc (NASDAQ:XBIT) on September 27th, 2018 at $3.22. In approximately 4 months, Xbiotech Inc has returned 94.71% as of today's recent price of $6.26.

XBIT : 9.19 (-2.34%)
Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting

XBiotech (NASDAQ: XBIT) announced today that findings from its open label, multicenter study using bermekimab to treat patients with moderate to severe atopic dermatitis (AD) will be presented at the "Late-Breaking...

XBIT : 9.19 (-2.34%)
Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain

Bermekimab Treats HS Patients Even After Failure with Leading Biological Therapy

XBIT : 9.19 (-2.34%)
Xbiotech Inc Shares Up 80.1% Since SmarTrend's Buy Recommendation (XBIT)

SmarTrend identified an Uptrend for Xbiotech Inc (NASDAQ:XBIT) on September 27th, 2018 at $3.22. In approximately 4 months, Xbiotech Inc has returned 80.09% as of today's recent price of $5.79.

XBIT : 9.19 (-2.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade XBIT with:

Business Summary

XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.

See More

Key Turning Points

2nd Resistance Point 9.92
1st Resistance Point 9.55
Last Price 9.19
1st Support Level 8.90
2nd Support Level 8.62

See More

52-Week High 11.74
Last Price 9.19
Fibonacci 61.8% 8.07
Fibonacci 50% 6.93
Fibonacci 38.2% 5.80
52-Week Low 2.13

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar